11532 Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

by February 26, 2021. To accommodate 

the significant interest in participation 

in the oral public comment session of 

ACIP meetings, each speaker will be 

limited to 3 minutes, and each speaker 

may only speak once per meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–03959 Filed 2–23–21; 11:15 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–21DC; Docket No. CDC–2021– 

0012] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled ‘National Syringe Services 

Program (SSP) Evaluation’, which 

proposes to: (1) Assess and monitor SSP 

operational characteristics and services, 

client characteristics and drug use 

patterns, client satisfaction, funding 

resources, community relations, and key 

operational and programmatic successes 

and challenges and (2) support timely 

analysis and dissemination of national 

program evaluation survey findings. 

DATES: CDC must receive written 

comments on or before April 26, 2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0012 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

National Syringe Services Program 

(SSP) Evaluation—New—National 

Center for HIV/AIDS, Viral Hepatitis, 

STD, and TB Prevention (NCHHSTP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

The primary purpose of the National 

Syringe Services Program (SSP) 

Evaluation is to strengthen and improve 

the capacity of SSPs to conduct regular 

monitoring and evaluation to ensure 

that comprehensive prevention services 

are provided to meet the needs of 

people who inject drugs (PWID) and 

reduce infectious disease and other 

harms related to intravenous drug use 

(IDU). The project will invite the 

participation of all SSPs that are listed 

in a publicly available directory of all 

known SSPs in the United States 

maintained by the North American 

Syringe Exchange Network (NASEN; 

https://nasen.org). SSPs will be sent a 

letter of invitation to participate in a 35- 

minute program survey. Participating 

programs will have the option of 

completing the survey via different 

modalities to enhance feasibility and 

comfort in completing the survey, for 

example via the Research Electronic 

Data Capture (REDCap) or a similarly 

secure web-based application. Other 

modalities for survey administration 

will include a coordinated telephone or 

videoconferencing interview. SSPs will 

be sent reminder letters for an 

approximately three-month data 

collection period. SSPs that do not 

respond to prior reminders will be sent 

one final reminder, and if the SSP still 

does not want to participate, one 

(optional) question on why the SSP did 

not complete the survey will be offered. 

The survey will include questions on 

operational characteristics and services, 

client characteristics and drug use 

patterns, client satisfaction, funding 

resources, community relations, and key 

operational successes and challenges. 

Approximately 400 SSPs will be able to 

Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices 11533 

participate in the survey. We anticipate 

that approximately 20% of SSPs will 

decline to complete the survey, yielding 

approximately 320 completed surveys 

per year. However, given that this is the 

first survey of SSPs funded by CDC and 

that the COVID–19 pandemic makes it 

challenging to predict future response 

rates, we are requesting enough burden 

hours to allow 100% of SSPs to respond 

to the survey. We estimate that it will 

take 35 minutes to complete the survey, 

regardless of how the respondent 

chooses to complete it (i.e., selfadministered online or intervieweradministered by phone or 

videoconferencing). SSPs that do not 

respond to the initial survey invitation 

will be given reminders to complete the 

survey over the duration of the survey 

implementation period. The final 

reminder will include a link to a single 

question for SSPs that choose not to 

complete the survey about why they 

declined to complete the survey. Given 

the uncertainties in response rates 

described above, we are requesting 

enough burden hours to allow 100% of 

SSPs to respond to this question. We 

estimate that it will take two minutes to 

respond to this question. 

OMB approval is requested for three 

years. The survey will be administered 

annually using the most updated 

national directory of SSPs during each 

survey administration. Participation is 

voluntary and there are no costs to 

respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

All participating SSPs ....................... National Syringe Services Program 

Evaluation Survey.

400 1 35/60 233 

Non-responding SSPs ...................... Non-Response Survey Item ............. 400 1 2/60 13 

Total ........................................... ........................................................... ........................ ........................ ........................ 246 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–03924 Filed 2–24–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–1266; Docket No. CDC–2021– 

0014] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled ‘‘HIV prevention among Latina 

transgender women who have sex with 

men: Evaluation of a locally developed 

intervention’’. The collection is part of 

a research study designed to evaluate 

the efficacy of a locally developed and 

culturally congruent two-session 

Spanish-language small-group 

intervention, ChiCAS (Chicas Creando 

Acceso a la Salud [Chicas: Girls Creating 

Access to Health]), which provides 

combination HIV prention services to 

adult Hispanic/Latina transgender 

women at high risk for HIV infection. 

DATES: CDC must receive written 

comments on or before April 26, 2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2121– 

0014 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road, NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or